GERN:NASDAQ
Geron Corp
$1.22
arrow_upward
+0.41%(+0.0050) 1D
$1.22
arrow_downward
-0.38% (-0.0047)bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GERN...
Open
$1.22
High
$1.26
Low
$1.21
Mkt. cap
787.03M
Avg. vol.
10.41M
Volume
5.64M
52-wk high
$2.01
52-wk low
$1.04
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
Open
$1.22
High
$1.26
Low
$1.21
Mkt. cap
787.03M
Avg. vol.
10.41M
Volume
5.64M
52-wk high
$2.01
52-wk low
$1.04
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
News stories
From web sources and news partners
Simply Wall Street
·
8 minutes ago
Is ZoomInfo Technologies (GTM) Cheap As Its ClickUp Integration Sparks Fresh Interest?
MarketBeat
·
4 minutes ago
Eagle Financial Services Inc. (NASDAQ:EFSI) Stock Has Consensus Price Target of $43.75
AOL.com
·
40 minutes ago
Vanguard's S&P 500 Index Fund Charges About $3 a Year on $10,000. The Average Stock Fund Charges About $40.
Yahoo Finance
·
12 hours ago
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees258
Founded1990
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegeron.com